Phoebe Yu (Peiwen)

Peiwen Yu, currently serves as Vice President, Discovery Biology at Exelixis, Inc. Dr. Yu has been an Exelixis veteran for more than 17 years joining the company in 2001 with a successful track record of her work on cabozantinib and cobimetinib. Her extensive experience has been involved in cancer drug discovery, late stage preclinical development, translational medicine, clinical trial management, and medical affairs. Although most of her career was spent at Exelixis, Dr. Yu started her career in industry at Hoffman-La Roche, Rigel, Inc., and OBI. The combination of that work provided Dr. Yu with more than 20 years of extensive experience in oncology drug discovery and development, immuno-oncology, inflammation, translational medicine, and medical affairs.

Dr. Yu received her Ph.D. in Immunology/Pathobiological Sciences from University of Wisconsin-Madison, BS and MS form National Taiwan University, and studied EMBA at NCCU 2016-2017. She also severed as a president of the Chinese Bioscience Association in 2012; and a board director of TFGHAA-NC in 2010-2011. 

On the RiverBien Page, Dr. Yu uses her experience in sketch, transparent watercolor, and ink painting to create paintings and share God’s words.